CDK12-IN-E9

CAS: 2020052-55-3 货号: C655988 分子式: C24H30N6O2 分子量: 434.53 PubChem CID: 122596923
有货
级别和纯度: 10mM in DMSO
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
C655988-1ml
期货 Stock Image
¥4,400.90
请输入您要添加的产品数量
🧪
为什么选择此级别

,适用于对基线干扰要求严格的色谱和分析工作流程。

🌡

储存与运输

-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。

📋

质量文档

SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。

📚

文献证明

在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。

概述


CDK12-IN-E9 is a potent and selective covalent CDK12 inhibitor and a non-covalent CDK9 inhibitor, while avoiding ABC transporter-mediated efflux. CDK12-IN-E9 has weak binding ability to CDK7/CyclinH complex with an IC 50 > 1 μM

In Vitro

CDK12-IN-E9 (E9; 10 nM-10 μM; 72 hours; Kelly, LAN5, SK-N-BE2, PC-9, NCI-H82 and NCI-H3122 cells) treatment shows potent antiproliferative activity in THZ1 R NB and lung cancer cells, with IC 50 values ranging from 8 to 40 nM. CDK12-IN-E9 (E9; 0-3000 nM; 6 hours; Kelly, PC-9, and NCI-H82 cells) treatment leads to a dose-dependent decrease in phosphorylated and total RNAPII in THZ1 r NB and lung cancer models, accompanied by decreased MYC and MCL1 expression. CDK12-IN-E9 also results in increased PARP cleavage, and an increase in the subGI population in THZ1 r lung cancer cells, while in NB cells, more of a G2/M arrest is seen after a 24-hr exposure to CDK12-IN-E9. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: Kelly, LAN5, SK-N-BE2, PC-9, NCI-H82 and NCI-H3122 cells Concentration: 10 nM-10 μM Incubation Time: 72 hours Result: Showed potent antiproliferative activity in THZ1 R NB and lung cancer cells, with IC 50 values ranging from 8 to 40 nM. Western Blot AnalysisCell Line: Kelly, PC-9, and NCI-H82 cells Concentration: 0 nM, 30 nM, 100 nM, 300 nM, 1000 nM, 3000 nM Incubation Time: 6 hours Result: Led to a dose-dependent decrease in phosphorylated and total RNAPII in THZ1 r NB and lung cancer models.

IC50& Target:CDK12 CDK9/cyclinT1 23.9 nM (IC 50 ) cdk2/cyclin A 932 nM (IC 50 ) CDK7/Cyclin H/MNAT1 1210 nM (IC 50 )

规格

规格或纯度
10mM in DMSO
英文名称
CDK12-IN-E9
生化机理
CDK12-IN-E9 是一种强效的选择性共价 CDK12 抑制剂和非共价 CDK9 抑制剂,同时可避免 ABC 转运体介导的外流。CDK12-IN-E9 与 CDK7/CyclinH 复合物的结合能力较弱,IC 50 > 1 μM。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
抑制剂
名称和识别符
分子类型
小分子
Isomeric SMILES
CCC1=C2N=C(C=C(N2N=C1)NC3=CC(=CC=C3)NC(=O)C=C)N4CCCC[C@H]4CCO
PubChem CID
分子量
434.53

技术文档

📋 安全数据表 (SDS)

全面的危险、操作、储存及法规合规文件。

下载 SDS →

✅ 分析证书 (COA)

批次质量数据。输入批号以获取对应 COA。

查询 COA →

📊 产品数据表

产品规格和应用的快速参考摘要。

查看数据表 →

🔬 规格说明书

该级别的完整质量属性和验收标准。

查看规格说明 →

高级数据

质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器